C31H45N7O5S — CID 167706622
(2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide (PubChem CID 167706622) has the molecular formula C31H45N7O5S and a molecular weight of 627.81 g/mol. Its IUPAC name is (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide.
| Compound Name | (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide |
|---|---|
| PubChem CID | 167706622 |
| Molecular Formula | C31H45N7O5S |
| Molecular Weight | 627.81 g/mol |
| Exact Mass | 627.32 |
| IUPAC Name | (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide |
| SMILES | CC(C)C[C@@H]1NC(=O)[C@@H](C)CCCCCC(=O)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)c2nc3ccccc3s2)NC1=O |
| InChI | InChI=1S/C31H45N7O5S/c1-18(2)16-23-28(42)37-24(17-20(39)11-6-4-5-10-19(3)27(41)36-23)29(43)35-22(13-9-15-34-31(32)33)26(40)30-38-21-12-7-8-14-25(21)44-30/h7-8,12,14,18-19,22-24H,4-6,9-11,13,15-17H2,1-3H3,(H,35,43)(H,36,41)(H,37,42)(H4,32,33,34)/t19-,22-,23-,24-/m0/s1 |
| InChIKey | JUXOBRXYOGKHDL-HCUBDLJJSA-N |
| XLogP | 2.59 |
| TPSA | 198.73 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 44 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 627.81 |
| LogP ≤ 5 | 2.59 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 8 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|